173 related articles for article (PubMed ID: 33253052)
1. Loco-regional drug delivery in oncology: current clinical applications and future translational opportunities.
Rossi SM; Murray T; McDonough L; Kelly H
Expert Opin Drug Deliv; 2021 May; 18(5):607-623. PubMed ID: 33253052
[No Abstract] [Full Text] [Related]
2. Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies.
Lencioni R
Oncology; 2010 Jul; 78 Suppl 1():107-12. PubMed ID: 20616592
[TBL] [Abstract][Full Text] [Related]
3. Loco-regional treatment of hepatocellular carcinoma.
Lencioni R
Hepatology; 2010 Aug; 52(2):762-73. PubMed ID: 20564355
[TBL] [Abstract][Full Text] [Related]
4. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects.
Lencioni R; Crocetti L; De Simone P; Filipponi F
Transpl Int; 2010 Jul; 23(7):698-703. PubMed ID: 20492618
[TBL] [Abstract][Full Text] [Related]
5. Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma.
Park W; Chen J; Cho S; Park SJ; Larson AC; Na K; Kim DH
ACS Appl Mater Interfaces; 2016 May; 8(20):12711-9. PubMed ID: 27159350
[TBL] [Abstract][Full Text] [Related]
6. Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
Savic LJ; Chapiro J; Duwe G; Geschwind JF
Hepat Oncol; 2016 Jan; 3(1):19-28. PubMed ID: 26989470
[TBL] [Abstract][Full Text] [Related]
7. Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC).
Berretta M; Cobellis G; Franco R; Panarese I; Rinaldi B; Nasti G; Di Francia R; Rinaldi L
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10139-10150. PubMed ID: 31799686
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
Facciorusso A
World J Gastroenterol; 2018 Jan; 24(2):161-169. PubMed ID: 29375202
[TBL] [Abstract][Full Text] [Related]
9. Transarterial therapies for hepatocellular carcinoma.
Sangro B; D'Avola D; Iñarrairaegui M; Prieto J
Expert Opin Pharmacother; 2011 May; 12(7):1057-73. PubMed ID: 21470073
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications.
Mikhail AS; Negussie AH; Mauda-Havakuk M; Owen JW; Pritchard WF; Lewis AL; Wood BJ
Expert Opin Drug Deliv; 2021 Mar; 18(3):383-398. PubMed ID: 33480306
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional microbeads for drug delivery in TACE.
Bannerman D; Wan W
Expert Opin Drug Deliv; 2016 Sep; 13(9):1289-300. PubMed ID: 27223469
[TBL] [Abstract][Full Text] [Related]
14. Development of thermosensitive chitosan/glicerophospate injectable in situ gelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study.
Salis A; Rassu G; Budai-Szűcs M; Benzoni I; Csányi E; Berkó S; Maestri M; Dionigi P; Porcu EP; Gavini E; Giunchedi P
Expert Opin Drug Deliv; 2015; 12(10):1583-96. PubMed ID: 25937030
[TBL] [Abstract][Full Text] [Related]
15. Non-surgical treatment of hepatocarcinoma.
Ravoet C; Bleiberg H; Gerard B
J Surg Oncol Suppl; 1993; 3():104-11. PubMed ID: 8389154
[TBL] [Abstract][Full Text] [Related]
16. Delivery approaches of gene therapy in hepatocellular carcinoma.
Duan F; Lam MG
Anticancer Res; 2013 Nov; 33(11):4711-8. PubMed ID: 24222105
[TBL] [Abstract][Full Text] [Related]
17. Examination of fabrication conditions of acrylate-based hydrogel formulations for doxorubicin release and efficacy test for hepatocellular carcinoma cell.
Bayramoglu G; Gozen D; Ersoy G; Ozalp VC; Akcali KC; Arica MY
J Biomater Sci Polym Ed; 2014; 25(7):657-78. PubMed ID: 24580096
[TBL] [Abstract][Full Text] [Related]
18. Loco-regional administration of nanomedicines for the treatment of lung cancer.
Garrastazu Pereira G; Lawson AJ; Buttini F; Sonvico F
Drug Deliv; 2016 Oct; 23(8):2881-2896. PubMed ID: 26585837
[TBL] [Abstract][Full Text] [Related]
19. Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRI.
Bonekamp D; Reyes DK; Bonekamp S; Wahlin TA; Geschwind JF; Fishman EK; Kamel IR
Emerg Radiol; 2011 Jun; 18(3):249-56. PubMed ID: 21327446
[TBL] [Abstract][Full Text] [Related]
20. An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.
Bimonte S; Barbieri A; Palaia R; Leongito M; Albino V; Piccirillo M; Arra C; Izzo F
Infect Agent Cancer; 2015; 10():9. PubMed ID: 25755676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
